0001291520-17-000002.txt : 20170628 0001291520-17-000002.hdr.sgml : 20170628 20170628150708 ACCESSION NUMBER: 0001291520-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170628 DATE AS OF CHANGE: 20170628 EFFECTIVENESS DATE: 20170628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289624 FILM NUMBER: 17934946 BUSINESS ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 D 1 primary_doc.xml X0707 D LIVE 0001497504 PLx Pharma Inc. 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 (713) 842-1249 DELAWARE Dipexium Pharmaceuticals, Inc. Dipexium Pharmaceuticals, LLC Corporation true Michael J. Valentino 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Executive Officer Director Gary Balkema 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Director Kirk Calhoun 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Director Robert Casale 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Director Natasha Giordano 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Executive Officer Director John Hadden 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Director David Luci 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Director David Jorden 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Executive Officer Gary Mossman 8285 El Rio Street Suite 130 Houston TX TEXAS 77054 Executive Officer Pharmaceuticals No Revenues 06b false 2017-06-14 false true true false 0 Raymond James & Associates, Inc. 705 None None 880 Carillon Parkway St. Petersberg FL FLORIDA 33716 CA CALIFORNIA FL FLORIDA NJ NEW JERSEY NY NEW YORK TX TEXAS VT VERMONT false Janney Montgomery Scott LLC 463 None None 1717 Arch Street Philadelphia PA PENNSYLVANIA 19103 CA CALIFORNIA FL FLORIDA NJ NEW JERSEY NY NEW YORK TX TEXAS VT VERMONT false 18191869 18191869 0 false 37 1191512 0 Sales commission reflects amount paid in connection with (i) this offering and (ii) a concurrent public offering of common stock, consisting of a $1,091,512 fee and expenses up to $100,000 (including legal fees up to $75,000). 0 No proceeds are proposed to be used for payments to such persons other than ordinary salary expenses that may be paid out of working capital. false PLx Pharma Inc. David Jorden David Jorden Acting CFO 2017-06-28